Author | Chau T. Dang, MD

Articles

Anthracyclines Are a Critical Component of Adjuvant Chemotherapy

February 18, 2011

The anthracyclines doxorubicin (A) and epirubicin (E) are among the most active agents for breast cancer.

Updates on Chemotherapeutic Options and Targeted Therapies

September 03, 2009

E-Updates in the Adjuvant Treatment of Breast Cancer, Volume 2Updates on Chemotherapeutic Options and Targeted Therapies

Supportive Care: More Than Just Treating Cancer

December 13, 2007

Strides made in the treatment of metastatic breast cancer (MBC) appear to prolong survival in some settings, but the cost in terms of quality of life (QOL) remains a concern. The previous four E-Updates in this series on metastatic breast cancer have focused on the various treatment options, including chemotherapy, anti-HER2 targeted therapy, antiangiogenic therapy, and hormonal therapy. In this E-Update, we turn to the role of supportive measures in the treatment of cancer, specifically as these measures relate to quality of life. These measures include the use of erythropoiesis-stimulating agents (ESA) and bisphosphonates, management of fatigue and pain, and psychological care.